PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
14551684-5	2003	eNOS activation was assessed by phosphorylation of the enzyme and its activity was evaluated by citrulline synthesis in human umbilical vein endothelial cells (HUVEC).	Citrulline	96-106	nitric oxide synthase 3	Bos taurus	0-4	
17822962-1	2007	Endothelial nitric oxide synthase (eNOS) catalyzes the conversion of L-arginine to L-citrulline and nitric oxide (NO), an important modulator of vascular function.	Citrulline	83-95	nitric oxide synthase 3	Bos taurus	0-33	
17822962-1	2007	Endothelial nitric oxide synthase (eNOS) catalyzes the conversion of L-arginine to L-citrulline and nitric oxide (NO), an important modulator of vascular function.	Citrulline	83-95	nitric oxide synthase 3	Bos taurus	35-39	
15743275-1	2005	eNOS (endothelial nitric oxide synthase) catalyses the conversion of L-arginine into L-citrulline and NO.	Citrulline	85-97	nitric oxide synthase 3	Bos taurus	0-4	
15743275-1	2005	eNOS (endothelial nitric oxide synthase) catalyses the conversion of L-arginine into L-citrulline and NO.	Citrulline	85-97	nitric oxide synthase 3	Bos taurus	6-39	
21914450-8	2011	Simvastatin induced an increase in eNOS mRNA expression and protein levels in the presence of arginine or citrulline.	Citrulline	106-116	nitric oxide synthase 3	Bos taurus	35-39	
22696221-1	2012	Endothelial nitric-oxide synthase (eNOS) utilizes l-arginine as its principal substrate, converting it to l-citrulline and nitric oxide (NO).	Citrulline	106-118	nitric oxide synthase 3	Bos taurus	0-33	
21914450-10	2011	Combining statin with arginine or citrulline increased NO production in endothelial cells by increasing eNOS protein levels.	Citrulline	34-44	nitric oxide synthase 3	Bos taurus	104-108